NIBEC (the Nano Intelligent Biomedical Engineering Corporation)’s transformative carrier platform is delivering macromolecular drugs to cell and tissue targets throughout the body with improved ...

Avacta Therapeutics (AIM: AVCT, ‘Avacta’, ‘the Company’), a clinical stage biopharmaceutical company developing pre|CISION ®, a tumor-activated oncology delivery platform, today announced the ...

Caitlyn Miller’s interest in cancer started when her stepfather was diagnosed with oral cancer when she was 10 years old. His diagnosis kicked off a 14-year battle that included different treatments ...

For all of the benefit that biologic drugs provide as treatments for chronic conditions, these medications also require chronic dosing by injection or infusion. Biotech companies have been pursuing ...

A new study describes one of the first entirely new drug delivery microencapsulation approaches in decades. A new study from the University of Michigan describes one of the first entirely new drug ...

(Nanowerk Spotlight) Cancer remains one of the most challenging diseases to treat, despite decades of research. While targeted therapies like epidermal growth factor receptor (EGFR) inhibitors have ...

Fail fast and fail cheap is the current mantra in drug discovery. This approach is based on the premise that elimination of high-risk compounds early in the discovery process increases the success ...

Taking medications on time, in the right dose and for the prescribed duration can be challenging for patients, and failure to do so comes with steep costs, causing 10% of hospitalizations and billions ...

Revolutionary progress, like that of GLP-1 drugs, happens when many exceptional people work together, following a robust ...